Scarica l'app Stockscreener
167.26
3.29%
5.32
Pre-mercato:
166.02
-1.24
-0.74%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché A Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$161.94
Aprire:
$163.08
Volume 24 ore:
3.78M
Relative Volume:
1.69
Capitalizzazione di mercato:
$47.16B
Reddito:
$7.23B
Utile/perdita netta:
$1.41B
Rapporto P/E:
33.59
EPS:
4.979
Flusso di cassa netto:
$1.09B
1 W Prestazione:
+11.31%
1M Prestazione:
+5.19%
6M Prestazione:
+50.28%
1 anno Prestazione:
+32.40%
Intervallo 1D:
$161.03
$167.59
Intervallo di 1 settimana:
$150.30
$167.59
Portata 52W:
$108.35
$167.59
Agilent Technologies Inc Stock (A) Company Profile
Nome
Agilent Technologies Inc
Settore
Industria
Telefono
(408) 345-8886
Indirizzo
5301 STEVENS CREEK BLVD, SANTA CLARA, CA
Compare A vs TMO, DHR, NTRA, IQV
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
A
Agilent Technologies Inc
|
167.26 | 41.42B | 7.23B | 1.41B | 1.09B | 4.979 |
TMO
Thermo Fisher Scientific Inc
|
658.52 | 225.48B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
221.09 | 140.70B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
390.90 | 47.41B | 2.50B | -226.32M | 71.51M | -1.6412 |
IQV
Iqvia Holdings Inc
|
270.09 | 43.09B | 16.63B | 1.39B | 2.12B | 8.0674 |
Agilent Technologies Inc Stock (A) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-20 | Iniziato | HSBC Securities | Buy |
| 2026-01-05 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-12-15 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2025-12-09 | Iniziato | Goldman | Buy |
| 2025-12-02 | Iniziato | Morgan Stanley | Overweight |
| 2025-10-08 | Iniziato | Rothschild & Co Redburn | Buy |
| 2025-10-08 | Aggiornamento | UBS | Neutral → Buy |
| 2025-02-10 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-07-10 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-06-27 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2024-06-03 | Ripresa | Jefferies | Hold |
| 2024-04-05 | Aggiornamento | Stifel | Hold → Buy |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-12-12 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-11-17 | Downgrade | UBS | Buy → Neutral |
| 2023-09-28 | Iniziato | Bernstein | Mkt Perform |
| 2023-07-31 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-05-24 | Reiterato | Barclays | Equal Weight |
| 2023-05-24 | Reiterato | BofA Securities | Buy |
| 2023-05-24 | Reiterato | Citigroup | Neutral |
| 2023-05-24 | Reiterato | Credit Suisse | Outperform |
| 2023-05-24 | Reiterato | Evercore ISI | Outperform |
| 2023-05-24 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-05-24 | Reiterato | Robert W. Baird | Outperform |
| 2023-05-24 | Reiterato | SVB Securities | Outperform |
| 2023-05-24 | Reiterato | Stifel | Hold |
| 2023-05-24 | Reiterato | TD Cowen | Outperform |
| 2023-05-24 | Reiterato | Wells Fargo | Overweight |
| 2023-05-11 | Iniziato | Barclays | Equal Weight |
| 2023-01-10 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-07-20 | Iniziato | UBS | Buy |
| 2022-07-08 | Downgrade | Citigroup | Buy → Neutral |
| 2022-04-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-02-23 | Reiterato | BofA Securities | Buy |
| 2022-02-23 | Reiterato | Citigroup | Buy |
| 2022-02-23 | Reiterato | Cowen | Outperform |
| 2022-02-23 | Reiterato | Evercore ISI | Outperform |
| 2022-02-23 | Reiterato | Stifel | Hold |
| 2022-02-23 | Reiterato | Wells Fargo | Overweight |
| 2021-11-23 | Reiterato | BofA Securities | Buy |
| 2021-11-23 | Reiterato | Cowen | Outperform |
| 2021-11-23 | Reiterato | Stifel | Hold |
| 2021-03-18 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-02-17 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2020-12-02 | Iniziato | Goldman | Buy |
| 2020-11-25 | Aggiornamento | UBS | Neutral → Buy |
| 2020-11-17 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-09-30 | Iniziato | Atlantic Equities | Neutral |
| 2020-08-19 | Reiterato | BofA Securities | Neutral |
| 2020-08-19 | Reiterato | Citigroup | Neutral |
| 2020-08-19 | Reiterato | Jefferies | Buy |
| 2020-08-19 | Reiterato | Robert W. Baird | Outperform |
| 2020-08-19 | Reiterato | SVB Leerink | Outperform |
| 2020-08-19 | Reiterato | Stifel | Hold |
| 2020-08-19 | Reiterato | Wells Fargo | Overweight |
| 2020-02-24 | Downgrade | Needham | Buy → Hold |
| 2020-01-08 | Iniziato | Wells Fargo | Overweight |
| 2020-01-07 | Iniziato | Citigroup | Neutral |
| 2019-11-26 | Reiterato | Needham | Buy |
| 2019-11-15 | Iniziato | Stifel | Hold |
| 2019-10-18 | Downgrade | UBS | Buy → Neutral |
| 2019-07-16 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2019-07-15 | Downgrade | Barclays | Overweight → Equal Weight |
Mostra tutto
Agilent Technologies Inc Borsa (A) Ultime notizie
Agilent Technologies Sees Growth From China, Replacement Cycles and Lab Automation - Yahoo Finance
Why Did Agilent Technologies (A) Shares Climb After Its Latest Update? - simplywall.st
Agilent Technologies price pierces price targetForecast today22-09-2026 - Economies.com
Global Metabolomics Market to Reach US$9.01 Billion by 2035 as Precision Medicine, Biomarker Discovery and Advanced Analytics Unlock New Opportunities - GlobeNewswire Inc.
Agilent Technologies stock gains 3.3 percent on strong results - AD HOC NEWS
Research Tools & Consumables Stocks Q2 Highlights: Agilent (NYSE:A) - tradingview.com
Agilent Technologies stock heads into the open after a 3.3% gain - AD HOC NEWS
Agilent Technologies Inc (A) Stock Up 3.5% but GF Value Says Ove - GuruFocus
Agilent Technologies Inc. stock outperforms competitors on strong trading day - MarketWatch
Agilent Technologies Inc (A): GF Score of 96 Signals Strong Outp - GuruFocus
Agilent Technologies stock gains on TapeStationDx launch and raised EPS guidance - AD HOC NEWS
Agilent launches clinical lab systems for DNA, RNA analysis By Investing.com - Investing.com Nigeria
Agilent launches clinical lab systems for DNA, RNA analysis - Investing.com
Agilent Launches TapeStationDx Systems for Clinical NGS Sample Quality Control - Yahoo Finance
Goldman Sachs Adjusts PT on Agilent Technologies to $185 From $175, Maintains Buy Rating - Moomoo
Agilent Technologies, Inc. (A) Stock Analysis: Unveiling a 11.81% Potential Upside in Diagnostics & Research - DirectorsTalk Interviews
Agilent Technologies stock heads into the open after a modest gain - AD HOC NEWS
Agilent Technologies stock rises on August 26 guidance lift - AD HOC NEWS
Agilent (A) Wants Pathology Labs To Go Digital, 540 Slides At A Time - Yahoo Finance
Agilent Technologies stock gains on fresh scanner launch and dividend - AD HOC NEWS
Is FDA Cleared Scanner Launch Altering The Investment Case For Agilent Stock? - simplywall.st
Agilent Technologies Inc. 2017 Q3ResultsEarnings Call Slides (NYSE:A) 2017-08-15 - Seeking Alpha
Agilent Technologies stock trades steadily as investors weigh recent earnings and margin outlook - AD HOC NEWS
CORRECTING and REPLACING Agilent Announces Cash Dividend of 25.5 Cents per Share - Yahoo Finance
Agilent Technologies, Inc. (A) Stock Forecasts - Yahoo Finance
Agilent Technologies Keeps Quarterly Dividend at $0.255 per Share - marketscreener.com
Agilent declares quarterly dividend of 25.5 cents per share - Investing.com
Press Release: Agilent Announces Cash Dividend of 25.5 Cents per Share - 富途牛牛
Agilent Technologies, Inc. (A) Stock Analysis: Exploring A 19% Upside Potential - DirectorsTalk Interviews
Jefferies Initiates Agilent Technologies(A.US) With Hold Rating, Announces Target Price $155 - Moomoo
Agilent Technologies stock edges lower as analysts keep upside targets - ad-hoc-news.de
Agilent Technologies stock heads into the open after a 1.2 percent drop - ad-hoc-news.de
Agilent’s CEO and CFO will join a London fireside chat Sept. 23 - Stock Titan
Agilent to Participate in J.P. Morgan U.S. All Stars Conference - Business Wire
Form 8K Agilent Technologies For: 10 September By Investing.com - Investing.com Canada
Agilent Technologies stock dips after insider buy and Q3 earnings strength - ad-hoc-news.de
Agilent files Form 3 initial beneficial ownership statement for director Glenn S. Boehnlein - Bitget
Insider Unloading: Mikael Dolsten Sells $95K Worth Of Agilent Technologies Shares - Benzinga
Major Purchase Alert: Glenn Boehnlein Invests $119K In Agilent Technologies Stock - Benzinga
Director at Agilent Technologies (A) gets 817-share stock grant - Stock Titan
Agilent (NYSE: A) director reports no direct stock - Stock Titan
Is Agilent Technologies Stock Outperforming the Dow? - inkl
AGILENT TECHNOLOGIES INC : UBS CUTS TO NEUTRAL FROM BUY - Bitget
Agilent Technologies Director Mikael Dolsten Reports Sale of 634 Shares - Kalkine Media
Agilent Technologies stock holds near 52-week high after guidance lift - ad-hoc-news.de
Agilent Technologies Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Agilent Technologies (NYSE: A) director unloads 634 shares in early September trade - Stock Titan
Agilent Technologies Shares Fall After UBS Downgrade - marketscreener.com
UBS Downgrades Agilent Technologies to Neutral From Buy, $165 Price Target - Moomoo
Agilent Technologies (NYSE: A) Announces 2027 Board Leadership Changes with New Chair and Director - Kalkine Media
Agilent appoints new board chair and independent director - The Globe and Mail
Agilent Technologies Inc Azioni (A) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.08%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):